IP Library Granted Patent US 7,355,002
Granted Patent B2
US 7,355,002 · App. 10/771,187 · Granted Apr 8, 2008

Secreted and transmembrane polypeptides and nucleic acids encoding the same

Assignee: Genentech, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,355,002
App. No.
10/771,187
Granted
Apr 8, 2008
Kind
B2
Abstract

The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.

Claims (19)

1. An isolated polypeptide having at least 95% amino acid sequence identity to:

(a) the amino acid sequence of the polypeptide of SEQ ID NO: 292;

(b) the amino acid sequence of the polypeptide of SEQ ID NO: 292, lacking its associated signal peptide; or

(c) the amino acid sequence of the polypeptide encoded by the full-length coding sequence of the cDNA deposited under ATCC accession number 209439,

wherein said polypeptide inhibits VEGF stimulated proliferation of endothelial cell growth.

2. The isolated polypeptide of claim 1 having at least 99% amino acid sequence identity to:

(a) the amino acid sequence of the polypeptide of SEQ ID NO: 292;

(b) the amino acid sequence of the polypeptide of SEQ ID NO: 292, lacking its associated signal peptide; or

(c) the amino acid sequence of the polypeptide encoded by the full-length coding sequence of the cDNA deposited under ATCC accession number 209439,

wherein said polypeptide inhibits VEGF stimulated proliferation of endothelial cell growth.

3. An isolated polypeptide comprising:

(a) the amino acid sequence of the polypeptide of SEQ ID NO: 292;

(b) the amino acid sequence of the polypeptide of SEQ lID NO: 292, lacking its associated signal peptide; or

(c) the amino acid sequence of the polypeptide encoded by the full-length coding sequence of the cDNA deposited under ATCC accession number 209439.

4. The isolated polypeptide of claim 3 comprising the amino acid sequence of the polypeptide of SEQ ID NO: 292.

5. The isolated polypeptide of claim 3 comprising the amino acid sequence of the polypeptide of SEQ ID NO: 292, lacking its associated signal peptide.

6. The isolated polypeptide of claim 3 comprising the amino acid sequence of the polypeptide encoded by the full-length coding sequence of the cDNA deposited under ATCC accession number 209439.

7. A chimeric polypeptide comprising a polypeptide according to claim 1 fused to a heterologous polypeptide.

8. The chimeric polypeptide of claim 1 , wherein said heterologous polypeptide is an epitope tag or an Fc region of an immunoglobulin.

Continuity (9)
Continuation 0990906400 · Jul 18, 2001
Continuation 0966535000 · Sep 18, 2000
Continuation PCTUS000441400 · Feb 22, 2000
Continuation In Part PCTUS981943700 · Sep 17, 1998
Continuation In Part PCTUS981933000 · Sep 16, 1998
Provisional Application 6008802600 · Jun 4, 1998
Provisional Application 6006677000 · Nov 24, 1997
Provisional Application 6006518600 · Nov 12, 1997
Related Publication 20040185531A1 · Sep 23, 2004